Literature DB >> 2118933

A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin.

J Kavaler1, A J Caton, L M Staudt, D Schwartz, W Gerhard.   

Abstract

Approximately 50% of the primary antibody response of BALB/c mice to the A/PR/8/34 influenza virus hemagglutinin is directed to the Cb site, one of the four major antigenic regions of the molecule. To determine the structural basis of the anti-Cb site response, we have examined the paratypic and genetic diversity exhibited by a panel of 24 primary and 4 secondary response mAb specific for this antigenic region. Reactivity pattern analysis demonstrated 20 distinct fine specificities among these antibodies, and V region gene sequence analysis showed that they are encoded by 17 different VH gene segments from 6 VH gene families and 14 different VK gene segments from 6 VK gene groups. Despite this overall diversity, many of the antibodies can be placed in a limited number of sets based on the shared expression of VH and/or VK genes. One set contains antibodies encoded by a single gene of the VK4/5 group in combination with one of two closely related genes from the J558 VH family. This set accounts for half of the Cb site-specific primary response hybridomas, indicating that the representation of the various anti-Cb site B cell specificities during the primary response to A/PR/8/34 influenza virus is not uniform. The preferential participation of B cells expressing this VH/VK combination is largely responsible for the dominance of anti-Cb site antibodies in the primary anti-hemagglutinin response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118933

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.

Authors:  Jing Qi Feng; Krystyna Mozdzanowska; Walter Gerhard
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Influenza-infected newborn and adult monkeys exhibit a strong primary antibody response to hemagglutinin stem.

Authors:  Elene Clemens; Davide Angeletti; Beth C Holbrook; Masaru Kanekiyo; Matthew J Jorgensen; Barney S Graham; Jonathan Yewdell; Martha A Alexander-Miller
Journal:  JCI Insight       Date:  2020-03-12

3.  Influenza Hemagglutinin Head Domain Mimicry by Rational Design.

Authors:  V Vamsee Aditya Mallajosyula; Shiv Swaroop; Raghavan Varadarajan
Journal:  Protein J       Date:  2020-10-17       Impact factor: 2.371

4.  Construction of a functional single-chain variable fragment antibody against hemagglutinin from Porphyromonas gingivalis.

Authors:  Y Shibata; K Kurihara; H Takiguchi; Y Abiko
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Specificity and VH sequence of two monoclonal antibodies against the N-terminus of dystrophin.

Authors:  G E Morris; C Nguyen
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

Review 6.  Self-reactive B cells in nonautoimmune and autoimmune mice.

Authors:  J Erikson; L Mandik; A Bui; A Eaton; H Noorchashm; K A Nguyen; J H Roark
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

7.  Anti-DNA IgA autoantibodies are spontaneously generated in mouse Peyer's patches.

Authors:  M Shimoda; Y Inoue; A Ametani; J Fujiwara; N M Tsuji; J Kurisaki; N Azuma; C Kanno
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

8.  B-cell fate decisions following influenza virus infection.

Authors:  Kristina Rothaeusler; Nicole Baumgarth
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

9.  E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.

Authors:  Rebecca J Greenwald; Joseph R Tumang; Anupama Sinha; Nicolas Currier; Robert D Cardiff; Thomas L Rothstein; Douglas V Faller; Gerald V Denis
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

10.  Identification of a novel latency-specific splice donor signal within the herpes simplex virus type 1 2.0-kilobase latency-associated transcript (LAT): translation inhibition of LAT open reading frames by the intron within the 2.0-kilobase LAT.

Authors:  J G Spivack; G M Woods; N W Fraser
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.